Global Artificial Vital Organs Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Artificial Vital Organs Market Insights, Forecast to 2034
Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ.
Market Analysis and InsightsGlobal Artificial Vital Organs Market
Global Artificial Vital Organs market is expected to reach to US$ 28510 million in 2023, with a positive growth of %, compared with US$ 26020 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Artificial Vital Organs industry is evaluated to reach US$ 47130 million in 2033. The CAGR will be 8.7% during 2023 to 2033.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
Report Covers
This report presents an overview of global Artificial Vital Organs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Artificial Vital Organs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Artificial Vital Organs introduction, etc. Artificial Vital Organs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Artificial Vital Organs
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Artificial Vital Organs Market
Global Artificial Vital Organs market is expected to reach to US$ 28510 million in 2023, with a positive growth of %, compared with US$ 26020 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Artificial Vital Organs industry is evaluated to reach US$ 47130 million in 2033. The CAGR will be 8.7% during 2023 to 2033.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
Report Covers
This report presents an overview of global Artificial Vital Organs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Artificial Vital Organs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Artificial Vital Organs introduction, etc. Artificial Vital Organs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Artificial Vital Organs
Chapter 13Methodology and Data Sources adopted by MRAResearch